Understanding Malaria: Etiology, Symptoms, and Treatment Strategies

4. Dihydroartemisinin + Piperaquine (DHA-PPQ)

  • Dosage (Adult): 3 tablets once daily for 3 days.

  • Advantages: Once daily dosing is convenient, long half-life, good tolerability.

Assortment of antimalarial drugs including ACT tablets and parenteral artesunate.

AI Generated, for reference only.

B. Treatment for P. vivax Malaria

Treatment for P. vivax is in two phases:

Phase 1 – Blood Stage Treatment Blood stage parasites are cleared with ACT or Chloroquine (where sensitivity exists).

  • Chloroquine Dosage (Adult):

    • Day 1: 600mg base followed by 300mg after 6-8 hours.

    • Day 2: 300mg base.

    • Day 3: 300mg base.

    • Total dose: 25mg/kg over 3 days.

Phase 2 – Radical Cure (Liver Stage Treatment)

P. vivax and P. ovale form hypnozoites in the liver which cause relapsePrimaquine is necessary to eliminate them.

  • Primaquine Dosage (Adult): 15mg base daily for 14 days.

  • Important Considerations:

    • Primaquine can cause hemolysis, especially in patients with G6PD deficiency. Testing is recommended before starting.

    • Contraindicated in pregnant and lactating women.

Treatment of Severe/Complicated Malaria

Severe malaria is a medical emergency and immediate treatment is essential. These patients should be admitted to the ICU.

A. Parenteral Artesunate (First Choice)

Parenteral artesunate is the first-line treatment according to WHO and Indian guidelines.

  • Dosage (Adult & Child):

    • 2.4mg/kg IV or IM at 0, 12, and 24 hours, then once daily until the patient can take oral medicines.

    • Minimum 3 doses are necessary even if the patient can take oral medicine early.

  • Preparation:

    • Reconstituted with 5% sodium bicarbonate, then diluted in 5% dextrose or normal saline.

  • Why Artesunate? Reduces mortality by up to 35% compared to Quinine.

B. Artesunate + Other Supportive Drugs

In severe malaria, complications must be managed:

Leave a Reply

Your email address will not be published. Required fields are marked *